Previous close | 5.50 |
Open | 5.50 |
Bid | 2.12 |
Ask | 5.95 |
Strike | 46.00 |
Expiry date | 2024-06-28 |
Day's range | 5.50 - 5.50 |
Contract range | N/A |
Volume | |
Open interest | N/A |
PRINCETON, N.J., June 21, 2024--Bristol Myers Squibb Announces U.S. FDA Accelerated Approval of KRAZATI® (adagrasib) in Combination with Cetuximab for Adult Patients with...
PRINCETON, N.J., June 21, 2024--European Medicines Agency Validates Bristol Myers Squibb's Application for Subcutaneous Nivolumab
PRINCETON, N.J., June 20, 2024--Bristol Myers Squibb to Report Results for Second Quarter 2024 on July 26, 2024